Shoei Corporation (9385.T)
JPY 570.0
(-0.18%)
JPY 570.0
(-0.18%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.42 Billion | 716.25 Million | 341.04 Million | -602.22 Million | 440.95 Million | 79.44 Million |
| Net Income | 1 Billion | -1.98 Billion | 168.98 Million | 1.07 Billion | 613.16 Million | 499.53 Million |
| Depreciation & Amortization | 243.52 Million | 379.97 Million | 360.53 Million | 195.72 Million | 188.58 Million | 132.41 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 425.63 Million | 75.9 Million | 292.72 Million | -1.85 Billion | -220.88 Million | -345.97 Million |
| Other non-cash items | -125.08 Million | 2.24 Billion | -481.2 Million | -17.69 Million | -139.91 Million | -206.52 Million |
| Investing Cash Flow | 507.68 Million | -116.32 Million | -1.76 Billion | -145.62 Million | -55.21 Million | -131.63 Million |
| Investments in PPE | -216.03 Million | -133.9 Million | -161.25 Million | -100.01 Million | -42.09 Million | -119.5 Million |
| Acquisitions | 706.87 Million | -11.42 Million | -1.55 Billion | - | 2.36 Million | - |
| Investment purchases | -14.05 Million | -13.38 Million | -14.31 Million | -13.91 Million | -12.72 Million | -14.58 Million |
| Sales/Maturities of investments | - | 7.32 Million | 5.64 Million | - | -2.36 Million | - |
| Other Investing Activities | 30.9 Million | 35.06 Million | -38.78 Million | -31.69 Million | -396 Thousand | 2.45 Million |
| Financing Cash Flow | -2.35 Billion | -217.11 Million | 1.35 Billion | 822.86 Million | -73.48 Million | -33.75 Million |
| Debt repayment | -2.2 Billion | -173.91 Million | -618.28 Million | -109.3 Million | -170.7 Million | -161.97 Million |
| Dividends payments | -154.37 Million | -154.55 Million | -154.96 Million | -124.43 Million | -131.01 Million | -84.56 Million |
| Common Stock Repurchased | - | - | - | -37 Thousand | -234.81 Million | - |
| Common Stock Issuance | - | - | - | 1.44 Billion | 463.04 Million | - |
| Other Financing Activities | -2.14 Billion | 111.35 Million | 2.13 Billion | -388.21 Million | -1000.00 | 212.77 Million |
| Accounts receivables | 254.21 Million | -137 Million | 466 Million | -300 Million | 24 Million | -78 Million |
| Accounts payables | -215.92 Million | -175.3 Million | -215.66 Million | -659.06 Million | -398.83 Million | 104.87 Million |
| Inventory | 316.69 Million | 432.13 Million | 57.04 Million | -726.28 Million | 49.81 Million | -372.52 Million |
| Other working capital | 70.64 Million | -43.93 Million | -14.66 Million | -165.79 Million | 104.13 Million | -323 Thousand |
| Cash at beginning of period | 1.26 Billion | 878.98 Million | 943.53 Million | 874.42 Million | 558.65 Million | 646.2 Million |
| Cash at end of period | 854.67 Million | 1.26 Billion | 878.98 Million | 943.53 Million | 874.42 Million | 558.65 Million |
| Capital Expenditure | -216.03 Million | -133.9 Million | -161.25 Million | -100.01 Million | -42.09 Million | -119.5 Million |
| Effect of forex changes on cash | 13.65 Million | 5.33 Million | 1.63 Million | -5.9 Million | 3.51 Million | -1.6 Million |
| Net cash flow / Change in cash | -412.46 Million | 388.14 Million | -64.54 Million | 69.11 Million | 315.76 Million | -87.54 Million |
| Free Cash Flow | 1.2 Billion | 582.34 Million | 179.79 Million | -702.23 Million | 398.86 Million | -40.05 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -130 Million | 1 Billion | 192 Million | 372 Million | 575 Million | -1.98 Billion |
| Depreciation & Amortization | - | 243.52 Million | 60.86 Million | 61.51 Million | 58.75 Million | 379.97 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 425.63 Million | - | - | - | 75.9 Million |
| Other non-cash items | 130 Million | -125.08 Million | -192 Million | -372 Million | -575 Million | 2.24 Billion |
| Investing Cash Flow | - | 507.68 Million | - | - | - | -116.32 Million |
| Investments in PPE | - | -216.03 Million | - | - | - | -133.9 Million |
| Acquisitions | - | 706.87 Million | - | - | - | -11.42 Million |
| Investment purchases | - | -14.05 Million | - | - | - | -13.38 Million |
| Sales/Maturities of investments | - | - | - | - | - | 7.32 Million |
| Other Investing Activities | - | 30.9 Million | - | - | - | 35.06 Million |
| Financing Cash Flow | - | -2.35 Billion | - | - | - | -217.11 Million |
| Debt repayment | - | -2.2 Billion | - | - | - | -173.91 Million |
| Dividends payments | - | -154.37 Million | - | - | - | -154.55 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -2.14 Billion | - | - | - | 111.35 Million |
| Accounts receivables | - | 254.21 Million | - | - | - | -137 Million |
| Accounts payables | - | -215.92 Million | - | - | - | -175.3 Million |
| Inventory | - | 316.69 Million | - | - | - | 432.13 Million |
| Other working capital | - | 70.64 Million | - | - | - | -43.93 Million |
| Cash at beginning of period | - | 1.26 Billion | 1.78 Billion | 1.33 Billion | 1.26 Billion | 878.98 Million |
| Cash at end of period | - | 854.67 Million | 939.07 Million | 1.78 Billion | 1.33 Billion | 1.26 Billion |
| Capital Expenditure | - | -216.03 Million | - | - | - | -133.9 Million |
| Effect of forex changes on cash | - | 13.65 Million | - | - | - | 5.33 Million |
| Net cash flow / Change in cash | - | -412.46 Million | -848.89 Million | 457.52 Million | 63.3 Million | 388.14 Million |
| Free Cash Flow | - | 1.2 Billion | 121.73 Million | 123.02 Million | 117.51 Million | 582.34 Million |
8030
8060
1468
PRIMESECU
AUROPHARMA
3075